The deregistration is a routine post-merger formality. No further public filings from AtaiBeckley are expected. Monitor Eli Lilly's filings for any integration updates or contingent value rights related to the acquisition.
Price Chart
Executive Summary
AtaiBeckley Inc. filed Form 15-12G to terminate its SEC registration under Section 12(g), effective September 21, 2026, following its acquisition by Eli Lilly and Company. The merger closed on September 11, 2026, with AtaiBeckley surviving as a wholly owned subsidiary of Eli Lilly, reducing the number of holders of record to one. This deregistration is a routine procedural step after the going-private transaction, confirming the company's exit from public reporting obligations.
Key Facts
- Form 15-12G filed to terminate registration under Section 12(g) of the Securities Exchange Act of 1934.
- Merger with Eli Lilly and Company closed on September 11, 2026, with AtaiBeckley surviving as a wholly owned subsidiary.
- Number of holders of record reduced to 1 as of the certification date.
- Deregistration effective September 21, 2026, following the completion of the merger.
- Nasdaq delisting (Form 25-NSE) was filed on September 11, 2026, confirming exit from public markets.
Financial Impact
No financial impact — deregistration is a procedural step after the merger with Eli Lilly. The acquisition price and terms are not disclosed in this filing.
Risk Factors
- No further public disclosures from AtaiBeckley — investors lose transparency on standalone operations.
- Any remaining minority shareholders (if any) may face illiquidity as the stock moves to OTC or is cancelled.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 15-12G Filing (Primary) | 0001140361-26-037188 |
| Document: 0001140361-26-037188-index-headers.html | 0001140361-26-037188 |
| Document: 0001140361-26-037188-index.html | 0001140361-26-037188 |
| Document: 0001140361-26-037188.txt | 0001140361-26-037188 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 21, 2026 5w ago | 15-12G | — | awaiting T+60 | — | — |
Sep 11, 2026 6w ago | 25-NSE | $7.30 | awaiting T+60 | — | — |
Aug 10, 2026 11w ago | DEFM14A | $7.25 | awaiting T+60 | — | — |
Aug 9, 2026 11w ago | Institutional Cluster | $7.25 | awaiting T+60 | — | — |
Jul 16, 2026 14w ago | DEFA14A / 8-K | $7.15 | awaiting T+60 | — | — |
Jul 7, 2026 15w ago | 144 | $5.17 | awaiting T+60 | — | — |
Jul 6, 2026 16w ago | Press Release | $4.96 | awaiting T+60 | — | — |
Jun 26, 2026 17w ago | 144 | $5.36 | awaiting T+60 | — | — |
Jun 25, 2026 17w ago | 144 | $5.29 | awaiting T+60 | — | — |
Jun 3, 2026 20w ago | 8-K | $4.53 $7.35 | ▲ +62.25% | ▲ +59.75% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers